SIRT2 and neuroblastoma: SIRT2 serves as an efficient “eraser” of multiple histone lactylation sites, targeting synthetic histone peptides, purified histones, nucleosomes, and histones in neuroblastoma (NB) cells (Zu et al., 2022).